ITRN vs NVDA

ITRN exhibits exceptional financial health with a Piotroski F-Score of 8/9, indicating strong operational efficiency and balance sheet strength. While the current price of $53.54 is a significant premium over the Graham Number ($26.84), it remains well below the growth-based intrinsic value of $67.31. The company combines steady double-digit growth with a highly attractive 11.21% dividend yield and negligible debt (D/E 0.02). Despite a bearish technical trend score and weak insider sentiment, the fundamental data suggests a high-quality compounder with significant margin of safety in its health metrics.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.